|
HY-P1048-1mg
|
MedChemexpress LLC
|
Myelin Basic Protein (MBP) (68-82), guinea pig [CAS 98474-59-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1048-10mg
|
MedChemexpress LLC
|
Myelin Basic Protein (MBP) (68-82), guinea pig [CAS 98474-59-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1048-5mg
|
MedChemexpress LLC
|
Myelin Basic Protein (MBP) (68-82), guinea pig [CAS 98474-59-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-122331-100mg
|
MedChemexpress LLC
|
Norbormide [CAS 991-42-4]
|
|
|
|
|
HY-150270A-10mg
|
MedChemexpress LLC
|
NP-1815-PX (sodium) [CAS 1239578-80-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-150270A-100mg
|
MedChemexpress LLC
|
NP-1815-PX (sodium) [CAS 1239578-80-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-150270A-25mg
|
MedChemexpress LLC
|
NP-1815-PX (sodium) [CAS 1239578-80-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-150270A-5mg
|
MedChemexpress LLC
|
NP-1815-PX (sodium) [CAS 1239578-80-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-150270A-50mg
|
MedChemexpress LLC
|
NP-1815-PX (sodium) [CAS 1239578-80-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-19102-10mg
|
MedChemexpress LLC
|
NSP-805 [CAS 125068-54-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-19102-20mg
|
MedChemexpress LLC
|
NSP-805 [CAS 125068-54-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-19102-5mg
|
MedChemexpress LLC
|
NSP-805 [CAS 125068-54-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-19102-1mL
|
MedChemexpress LLC
|
NSP-805 [CAS 125068-54-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-106961-10mg
|
MedChemexpress LLC
|
ONO 1301 [CAS 176391-41-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-106961-100mg
|
MedChemexpress LLC
|
ONO 1301 [CAS 176391-41-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-106961-25mg
|
MedChemexpress LLC
|
ONO 1301 [CAS 176391-41-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-106961-5mg
|
MedChemexpress LLC
|
ONO 1301 [CAS 176391-41-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-106961-50mg
|
MedChemexpress LLC
|
ONO 1301 [CAS 176391-41-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-135976-10mg
|
MedChemexpress LLC
|
P2X3 antagonist 34 [CAS 2417288-67-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-135976-100mg
|
MedChemexpress LLC
|
P2X3 antagonist 34 [CAS 2417288-67-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-135976-5mg
|
MedChemexpress LLC
|
P2X3 antagonist 34 [CAS 2417288-67-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-135976-50mg
|
MedChemexpress LLC
|
P2X3 antagonist 34 [CAS 2417288-67-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-135976-1mL
|
MedChemexpress LLC
|
P2X3 antagonist 34 [CAS 2417288-67-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-108511-10mg
|
MedChemexpress LLC
|
PB28 (dihydrochloride) [CAS 172907-03-8]
|
|
COVID-19-anti-virus
|
|
|
HY-108511-100mg
|
MedChemexpress LLC
|
PB28 (dihydrochloride) [CAS 172907-03-8]
|
|
COVID-19-anti-virus
|
|
